SATERA Trademark

Trademark Overview

On Sunday, September 20, 2020, a trademark application was filed for SATERA with the United States Patent and Trademark Office. The USPTO has given the SATERA trademark a serial number of 90194897. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, November 13, 2023. This trademark is owned by Axon Therapies, Inc.. The SATERA trademark is filed in the Medical Instrument Products category with the following description:

Medical and surgical systems comprised of a medical and surgical catheter, parts and fittings therefor, and an electric generator for intravascular ablation of neural pathways for use in interventional procedures
satera

General Information

Serial Number90194897
Word MarkSATERA
Filing DateSunday, September 20, 2020
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, November 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements

Goods and ServicesMedical and surgical systems comprised of a medical and surgical catheter, parts and fittings therefor, and an electric generator for intravascular ablation of neural pathways for use in interventional procedures

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 22, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAxon Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95051
Party NameAxon Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10018

Trademark Events

Event DateEvent Description
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU EXTENSION 1 GRANTED
Monday, November 13, 2023SOU EXTENSION 1 FILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, February 22, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 22, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, February 22, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, November 7, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 7, 2022FINAL REFUSAL E-MAILED
Monday, November 7, 2022FINAL REFUSAL WRITTEN
Friday, July 1, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, December 13, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 13, 2021LETTER OF SUSPENSION E-MAILED
Monday, December 13, 2021SUSPENSION LETTER WRITTEN
Thursday, August 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 11, 2021NON-FINAL ACTION E-MAILED
Thursday, February 11, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2021ASSIGNED TO EXAMINER
Wednesday, October 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 23, 2020NEW APPLICATION ENTERED

Related Keywords

satera medical surgical ablation intravascular neural pathways procedures interventional generator therefor